Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity

被引:59
作者
Chaves Valadao, Ana Luiza [1 ]
Abreu, Celina Monteiro [1 ]
Dias, Juliana Zanatta [1 ]
Arantes, Pablo [2 ]
Verli, Hugo [2 ]
Tanuri, Amilcar [1 ]
de Aguiar, Renato Santana [1 ]
机构
[1] Univ Fed Rio de Janeiro, Lab Virol Mol, Dept Genet, Inst Biol, BR-21941902 Rio De Janeiro, Brazil
[2] Univ Fed Rio Grande do Sul, Grp Bioinformat Estrutural, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil
关键词
HIV-1; emetine; Reverse Transcriptase; PBMC; resistance; IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE; IN-VITRO; RNASE-H; IDENTIFICATION; MICROBICIDES; PROPHYLAXIS; MECHANISM; DOMAINS;
D O I
10.3390/molecules200611474
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Ipecac alkaloids are secondary metabolites produced in the medicinal plant Psychotria ipecacuanha. Emetine is the main alkaloid of ipecac and one of the active compounds in syrup of Ipecac with emetic property. Here we evaluated emetine's potential as an antiviral agent against Human Immunodeficiency Virus. We performed in vitro Reverse Transcriptase (RT) Assay and Natural Endogenous Reverse Transcriptase Activity Assay (NERT) to evaluate HIV RT inhibition. Emetine molecular docking on HIV-1 RT was also analyzed. Phenotypic assays were performed in non-lymphocytic and in Peripheral Blood Mononuclear Cells (PBMC) with HIV-1 wild-type and HIV-harboring RT-resistant mutation to Nucleoside Reverse Transcriptase Inhibitors (M184V). Our results showed that HIV-1 RT was blocked in the presence of emetine in both models: in vitro reactions with isolated HIV-1 RT and intravirion, measured by NERT. Emetine revealed a strong potential of inhibiting HIV-1 replication in both cellular models, reaching 80% of reduction in HIV-1 infection, with low cytotoxic effect. Emetine also blocked HIV-1 infection of RT M184V mutant. These results suggest that emetine is able to penetrate in intact HIV particles, and bind and block reverse transcription reaction, suggesting that it can be used as anti-HIV microbicide. Taken together, our findings provide additional pharmacological information on the potential therapeutic effects of emetine.
引用
收藏
页码:11474 / 11489
页数:16
相关论文
共 65 条
[1]
Vpr.A3A chimera inhibits HIV replication [J].
Aguiar, Renato S. ;
Lovsin, Nika ;
Tanuri, Amilcar ;
Peterlin, B. Matija .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (05) :2518-2525
[2]
Development of a new methodology for screening of human immunodeficiency virus type 1 microbicides based on real-time PCR quantification [J].
Aguiar, Renato S. ;
Costa, Luciana J. ;
Pereira, Helena S. ;
Brindeiro, Rodrigo M. ;
Tanuri, Amilcar .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) :638-644
[3]
[Anonymous], 2014, GAP REP 2014 PEOPL L
[4]
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women [J].
Baeten, J. M. ;
Donnell, D. ;
Ndase, P. ;
Mugo, N. R. ;
Campbell, J. D. ;
Wangisi, J. ;
Tappero, J. W. ;
Bukusi, E. A. ;
Cohen, C. R. ;
Katabira, E. ;
Ronald, A. ;
Tumwesigye, E. ;
Were, E. ;
Fife, K. H. ;
Kiarie, J. ;
Farquhar, C. ;
John-Stewart, G. ;
Kakia, A. ;
Odoyo, J. ;
Mucunguzi, A. ;
Nakku-Joloba, E. ;
Twesigye, R. ;
Ngure, K. ;
Apaka, C. ;
Tamooh, H. ;
Gabona, F. ;
Mujugira, A. ;
Panteleeff, D. ;
Thomas, K. K. ;
Kidoguchi, L. ;
Krows, M. ;
Revall, J. ;
Morrison, S. ;
Haugen, H. ;
Emmanuel-Ogier, M. ;
Ondrejcek, L. ;
Coombs, R. W. ;
Frenkel, L. ;
Hendrix, C. ;
Bumpus, N. N. ;
Bangsberg, D. ;
Haberer, J. E. ;
Stevens, W. S. ;
Lingappa, J. R. ;
Celum, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) :399-410
[5]
OBSERVATIONS ON MECHANISM OF EMETINE POISONING OF MYOCARDIAL TISSUE [J].
BELLER, BM .
CIRCULATION RESEARCH, 1968, 22 (04) :501-+
[6]
Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[7]
HIGH-LEVEL RESISTANCE TO (-) ENANTIOMERIC 2'-DEOXY-3'-THIACYTIDINE IN-VITRO IS DUE TO ONE AMINO-ACID SUBSTITUTION IN THE CATALYTIC SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
BOUCHER, CAB ;
CAMMACK, N ;
SCHIPPER, P ;
SCHUURMAN, R ;
ROUSE, P ;
WAINBERG, MA ;
CAMERON, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2231-2234
[8]
The Safety, Persistence, and Acceptability of an Antiretroviral Microbicide Candidate UC781 [J].
Bunge, Katherine ;
Macio, Ingrid ;
Meyn, Leslie ;
Noguchi, Lisa ;
Parniak, Michael A. ;
Schwartz, Jill L. ;
Moncla, Bernard ;
Hillier, Sharon .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (04) :337-343
[9]
Celum Connie L, 2011, Top Antivir Med, V19, P181
[10]
De Clercq E, 2000, MED RES REV, V20, P323, DOI 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO